Skip to main content
. 2022 Mar 23;8(1):70–77. doi: 10.5114/ceh.2022.114190

Table 1.

Baseline characteristics of 108 patients before percutaneous transhepatic biliary drainage

Characteristics Value
Age (years), mean (SD), n (%) 61.7 ±10.9
> 70 years 28 (25.9)
≤ 70 years 80 (74.1)
Sex, male/female 72/36
ECOG performance status, n (%)
1 18 (16.7)
2 50 (46.3)
3 26 (24.1)
4 14 (12.9)
Tumour type, n (%)
Pancreatic carcinoma 34 (31.5)
Cholangiocarcinoma 20 (18.5)
Hepatocellular carcinoma 20 (18.5)
Digestive tract invasion 11 (10.2)
Gallbladder carcinoma 9 (8.3)
Lymph node metastasis 8 (7.4)
Other 6 (5.6)
Obstruction level, n (%)
Hilar 27 (25)
Non-hilar 81 (75)
Liver metastases, n (%)
Present 35 (32.4)
Absent 73 (67.6)
Serum bilirubin level prior to PTBD, n (%)
> 342 µmol/l 43 (39.8)
≤ 342 µmol/l 65 (61.2)
Duration from onset of jaundice to PTBD, days, median (IQR) 16 (8.5-23)
Hospital stay, days, median (IQR) 9 (4-17)

ECOG – Eastern Cooperative Oncology Group; PTBD – percutaneous transhepatic biliary drainage